Literature DB >> 11178608

Acute urinary retention and surgery for benign prostatic hyperplasia: the patient's perspective.

Jun Kawakami1, J. Curtis Nickel.   

Abstract

It is now possible to reduce the risk of acute urinary retention (AUR) and prostate surgery in patients suffering from symptomatic benign prostatic hyperplasia (BPH) with medical therapy. The objective of this study was to determine the concern and perceived impact on quality of life (QoL) of these potential events in patients at risk. Seventy-four consecutive patients with a diagnosis of BPH, but no history of AUR or prostate surgery referred to a single urology practice completed an AUA/BPH symptom index (AUA-SI), AUA BPH impact index, QoL assessment, and a comprehensive questionnaire (before and after counseling). This questionnaire explored their concern and opinion regarding the perceived impact of AUR or surgery on their personal QoL. Sixty-two patients (mean age 69.5) with an average AUA BPH Symptom Index of 12.2 were eligible for analysis. Over half of the patients were significantly concerned about the prospect of AUR (57%) and two thirds of the patients (67%) were significantly concerned about the prospect of surgery. However, more patients considered the insertion of a catheter for acute urinary retention would be more detrimental to their quality of life than surgery (68% vsersus 45%). More patients believed that catheterization would be more of a problem in their life than surgery (69% versus 52%). Patients with BPH at risk for future acute urinary retention and surgery generally felt that the potential occurrence of these events were of a major concern and if they occurred would be an important event affecting their personal quality of life.

Entities:  

Year:  1999        PMID: 11178608

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  7 in total

Review 1.  Drug treatments for lower urinary tract symptoms secondary to bladder outflow obstruction: focus on quality of life.

Authors:  Donald MacDonald; Thomas A McNicholas
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Patient's behavior and attitudes toward the management of benign prostatic hyperplasia among patients with the risk of disease progression: prospective study by "Prostate and Expectations of Treatment Epidemiology Research (PETER) study group".

Authors:  Peter Weibl; Tobias Klatte; Peter Laurinc; Roman Tomaškin; Shahrokh F Shariat; Miroslav Helbich; Danica Fackovcova; Peter Bujdák
Journal:  Wien Klin Wochenschr       Date:  2014-12-02       Impact factor: 1.704

3.  Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia.

Authors:  Kevin T McVary; Bradley Holland; J Randolf Beahrs
Journal:  Prostate Cancer Prostatic Dis       Date:  2019-11-18       Impact factor: 5.554

Review 4.  Modern advancements in minimally invasive surgical treatments for benign prostatic obstruction.

Authors:  John Pascoe; Christina Fontaine; Hashim Hashim
Journal:  Ther Adv Urol       Date:  2021-07-16

5.  Understanding patient and physician perceptions of benign prostatic hyperplasia in Europe: The Prostate Research on Behaviour and Education (PROBE) Survey.

Authors:  M Emberton; M Marberger; J de la Rosette
Journal:  Int J Clin Pract       Date:  2007-11-19       Impact factor: 2.503

6.  Identification of the patient with enlarged prostate: diagnosis and guidelines for management.

Authors:  Steven A Kaplan
Journal:  Osteopath Med Prim Care       Date:  2007-07-09

Review 7.  Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management.

Authors:  M Emberton; E B Cornel; P F Bassi; R O Fourcade; J M F Gómez; R Castro
Journal:  Int J Clin Pract       Date:  2008-05-08       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.